Ophthalmic Genetics

Ophthalmic genetics includes determination of patterns and risks of inheritance and development of treatments for genetic diseases. Vitamin A deficiency is the leading cause of preventable blindness in children worldwide and results in a well-recognized ocular phenotype. It is also includes the several technique in correcting the defective gene by using application of biotechnology techniques such as gene therapy. Ophthalmic genetics or ophthalmic gene therapy can process through by following methods like ocular gene transfer methods. They have been several diseases which have been cured by gene therapy like retinitis pigmentosa and ARMD.

 

 

  • Abnormalities of Nuclear or Mitochondrial DNA
  • Autosomal dominant disorders
  • Autosomal recessive disorders
  • X-linked recessive disorders
  • Matrilineal inheritance
  • Chromosomal Abnormalities

Related Conference of Ophthalmic Genetics

February 17-18, 2025

11th Global Ophthalmology Meeting

Amsterdam, Netherlands
February 24-25, 2025

9th World Congress on Eye and Vision

Madrid, Spain
March 17-18, 2025

39th European Ophthalmology Congress

Berlin, Germany
April 07-08, 2025

6th World congress on Ophthalmology and Optometry

Amsterdam, Netherlands
April 29-30, 2025

35th International Congress on Vision Science and Eye

Barcelona, Spain
April 29-30, 2025

6th World Congress on Ophthalmology and Vision Science

Barcelona, Spain
June 12-13, 2025

6th International Conference on Optometry

London, UK
June 17-18, 2025

25th Global Ophthalmologists Annual Meeting

Copenhagen, Denmark

Ophthalmic Genetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in